<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 24 - Mims</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page23.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../index.html#p=24">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 24 - Mims</div>
        <div id="content-top2">P. 24</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../index.html#p=24"><img src="../thumb/24.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>14     TreaTmenT approaches
                                                                                                                                                                     LARGEST

          technique of  bP measurements, and increased   undergo 24-hour abPM or home bP-monitoring to
                                     5,6
          use of out-of-office bP measurement.   In South   exclude masked hypertension (normal office, but                                                         CVS
          africa, this is ≥140/90 mmHg and is traditionally   high abPM or home bP). If masked hypertension   Prescribe a Pharma Dynamics product.
          based on a series of office blood-pressure   is present, it needs to be treated.                                                                           COMPANY
          measurements, repeated over a period of weeks                                               It’s a smart call.
                       8
          or even months.  However, office  bP is not as   assessMent of hypertensive                                                                                   IN SA   1
          accurate as both home bP or 24-hour ambulatory   organ DaMage
          bP-monitoring (abPM) because of the white   the  principal  effects  of  hypertension  are  in  the
          coat effect, and the latter is a better predictor of   small vessels of the brain, kidneys and eyes, and   CALCIUM CHANNEL   CALCIUM CHANNEL   ANTIPLATELET  THIAZIDE-LIKE   SULPHONYLUREA
                                                                                                                                                      DIURETIC
                                                                                                         BLOCKER
                                                                                                                        BLOCKER
          hypertensive organ damage.  Furthermore, the   the pressure effects on the heart.  assessment
          24-hour abPM gives information about nocturnal   of organ damage can be undertaken by clinical
                                                                                                                                     Pharma Dynamics
          bP, which is the most important predictor of   examination and basic tests.                                               clopidogrel
                                                                                                                        nifedipine
                                                                                                        amlodipine
          adverse  cardiovascular  (Cv)  outcome.   a  simple   elevated pressure in the vascular system leads   5 mg, 10 mg  30 mg, 60 mg  75 mg     SR 1,5 mg      SR 30 mg
                                      9
          algorithm (see Figure 1) shows recommendations   to left ventricular hypertrophy (lvH). lvH can be
          of incorporating both office and out-of-office bP   detected clinically by a pressure-overloaded apex
          in the initial diagnosis.               and a fourth heart sound, but this assessment
                          10
            automated office  bP (aobP) refers to un-  may be unreliable. eCG is a basic test available to   ACE INHIBITOR  ACE INHIBITOR  STATIN   ARB / DIURETIC     ARB
          observed  bP measurement by an automated   the practitioner that is often overlooked, to the
          device that has been increasingly recognised   detriment of the patient. the presence of eCG lvH   Pearinda  enap
          as a better assessment of office  bP because it   in the Framingham study significantly increased   perindopril tert-  enalapril maleate  atorvastatin  losartan   losartan potassium
          tends to mitigate the white coat effect.  Home   the possibility of cardiovascular events (Cv) by   butylamine  5 mg, 10 mg,  10 mg, 20 mg,  potassium / HCTZ  50 mg, 100 mg
                                       11
                                                                                                                                                    50 mg / 12,5 mg
          bP-monitoring should be done over seven   40%. the specificity is good, but it lacks sensitivity   4 mg, 8 mg  20 mg        40 mg, 80 mg   100 mg / 25 mg
          days, with three  bPs taken in the morning and   for a variety of reasons.  lvH is best determined by
          evening, and an average of all readings taken to   any one of the following three criteria:  ACE / DIURETIC  ACE / DIURETIC    ARB            ARB          PERIPHERAL
          define hypertension. the threshold values for the      the  Sokolow-lyon  criteria  –  adding  the                                                       VASODILATOR
          diagnosis of hypertension are shown in table 2.   8    amplitude of the S wave in  v1 plus the     Pearinda
          out-of-office  bP measurement is important   r wave in v5 or v6. If the sum is ≥35mm,                      enap-co
          in assessing patients with apparent treatment   lvH is present                               perindopril tert-  enalapril                   irbesartan
          resistance, who may be super-sensitive to the      Cornell  voltage criteria (the  sum of the   butylamine /  maleate / HCTZ  telmisartan  150 mg, 300 mg
                                                                                                        indapamide
          white coat.                                  amplitude of the  r wave in avl + the           4 mg / 1,25 mg  20 mg / 12,5 mg  40 mg, 80 mg
            Patients with borderline hypertension must be   S wave in v3+ 6 in females) x QrS duration
          assessed for other Cv-risk factors and target organ   &gt;2440 mm/ms                             ß BLOCKER      ß BLOCKER      ß BLOCKER /    α BLOCKER     PDE5 INHIBITOR
                                                                                                                                       DIURETIC
          damage, and they must be followed up long-term      the r wave in avl &gt;11 mm.
                                                                          8
          as they are likely to develop hypertension in time.   because of the complexity of the Cornell voltage,
          lifestyle changes need to be instituted and other   it is recommend that the practitioner use  the           bilocor         bisoprolol
          Cv-risk factors treated, e.g. statins for increased   Sokolow-lyon and the r wave in a vl assessment .  carvedilol  bisoprolol fumarate  fumarate / HCTZ  doxazosin 4 mg  sildenaﬁ l
          cholesterol. If overt target-organ damage is   assessment of hypertensive kidney damage     6,25 mg, 12,5 mg,   5 mg, 10 mg  2,5 mg / 6,25 mg             50 mg, 100 mg
                                                                                                                                      5 mg / 6,25 mg
          present or the patient is assessed as very high   includes the results of urine dipsticks, urinary   25 mg                 10 mg / 6,25 mg
          Cv-risk, it is recommended that these patients   albumin creatinine ratio, serum creatinine and
          Table 2. Thresholds for the diagnosis of hypertension by different methods   8
                               clinic      Home         Ambulatory

           Predicts outcome    Yes         Yes          Strongly
                                                                                                     For further product information contact PHARMA DYNAMICS P O Box  30958  Tokai  Cape Town  7966    Fax + 27 21 701 5898
                                                                                                     Email info@pharmadynamics.co.za   CUSTOMER CARE LINE 0860 PHARMA (742 762) / + 27 21 707 7000   www.pharmadynamics.co.za
           Initial diagnosis   Yes         Yes          Yes
                                                                                                     AMLOC 5, 10 mg. Each tablet contains amlodipine maleate equivalent to 5, 10 mg amlodipine respectively. S3 A38/7.1/0183, 0147. NAM NS2 06/7.1/0011, 0012. BILOCOR 5, 10. Each tablet contains
                                                                                                     5, 10 mg bisoprolol fumarate respectively. S3 A38/5.2/0053, 0051. NAM NS2 06/5.2/0061, 0062. BILOCOR CO 2,5/6,25, 5/6,25, 10/6,25. Each tablet contains 2,5, 5, 10 mg bisoprolol fumarate
                                                        120/70 (mean night)                          respectively and 6,25 mg hydrochlorothiazide. S3 A44/7.1.3/1010, 1011, 1012. NAM NS2 13/7.1.3/0260, 0261, 0262. CARVETREND 6,25, 12,5, 25 mg. Each tablet contains 6,25, 12, 25 mg
           Cut-off bP levels (in mmHg)  140/90  135/85                                               carvedilol respectively. S3 A37/7.1.3/0276, 0277, 0278. NAM NS2 08/7.1.3/0105, 0104, 0103. CARZIN XL. Each tablet contains 4 mg doxazosin. S3 A41/7.1/0557. NAM NS2 10/34/0376. PHARMA
                                                        135/85 (mean day)
                                                                                                     DYNAMICS CLOPIDOGREL 75 mg. Each tablet contains 75 mg clopidogrel. S3 A42/8.2/0128. NAM NS2 10/7.1/0377. DYNAFIL 50, 100 mg. Each tablet contains 50, 100 mg sildenaﬁ l respectively.
                                                                                                     S4 A42/7.1.5/1071, 1072. NAM NS2 13/7.1.5/0086, 0087. DYNA GLICLAZIDE SR 30 mg. Each tablet contains 30 mg gliclazide. S3 A42/21.2/0249. NAM NS2 12/21.2/0110. DYNA INDAPAMIDE
           evaluation of treatment  Yes    Yes          limited but valuable                         SR. Each tablet contains 1,5 mg indapamide. S3 A42/7.1/0790. NAM NS2 12/7.1/0138. DYNARB 150, 300 mg. Each tablet contains 150, 300 mg irbesartan respectively. S3 A43/7.1.3/0720, 0721.
                                                                                                     NAM NS2 12/7.1.3/0223, 0224. DYNA-PENTOXIFYLLINE SR. Each tablet contains 400 mg pentoxifylline. S2 A36/8/0282. NAM NS1 08/8/0183. DYNATOR 10, 20, 40, 80 mg. Each tablet contains
                                                                                                     10, 20, 40, 80 mg atorvastatin respectively. S4 A43/7.5/0167, 0168, 0169, 0170. NAM NS2 13/7.5/0111, 0112, 0113, 0114. ENAP 5, 10, 20 mg. Each tablet contains 5, 10, 20 mg enalapril maleate
           assess diurnal rhythm  no       no           Yes                                          respectively. S3 A34/7.1.3/0085, 0086, 0087. NAM NS2 04/7.1.3/1138, 1137, 1136. ENAP-CO. Each tablet contains 20 mg enalapril maleate and 12,5 mg hydrochlorothiazide. S3 A34/7.1.3/0088.
                                                                                                     NAM NS2 04/7.1.3/1135. FEDALOC 30, 60 mg SR. Each tablet contains 30, 60 mg nifedipine respectively. S3 A37/7.1/0302, 0303. NAM NS2 10/7.1/0033, 0034. PEARINDA 4, 8. Each tablet contains
                                                                                                     4, 8 mg perindopril tert-butylamine respectively. S3 A41/7.1.3/0649, 0650. NAM NS2 10/7.1.3/0476, 0477. PEARINDA PLUS 4. Each tablet contains 4 mg perindopril tert-butylamine and 1,25 mg
                                                                                                     indapamide. S3 A41/7.1.3/0633. NAM NS2 10/7.1.3/0611. TESAR 40, 80 mg. Each tablet contains 40, 80 mg telmisartan respectively. S3 A45/7.1.3/0978, 0979. NAM NS2 17/7.1.3/0023, 0024.
                                                                                                     ZARTAN 50, 100 mg. Each tablet contains 50, 100 mg losartan potassium respectively. S3 A41/7.1.3/0287, 0289. NAM NS2 08/7.1.3/0067, 0086. ZARTAN CO 50/12,5, 100/25. Each tablet contains
          MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS  VOLUME 1           50, 100 mg losartan potassium and 12,5, 25 mg hydrochlorothiazide respectively. S3 A42/7.1.3/1068, 1069. NAM NS2 12/7.1.3/0070, 0071. For full prescribing information, refer to the professional
                                                                                                     information approved by SAHPRA. 1) IMS MAT UNITS Feb 2019. CVSRJ598/04/2019.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page23.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page19.html">19</a>&nbsp;&nbsp;&nbsp;<a href="page20.html">20</a>&nbsp;&nbsp;&nbsp;<a href="page21.html">21</a>&nbsp;&nbsp;&nbsp;<a href="page22.html">22</a>&nbsp;&nbsp;&nbsp;<a href="page23.html">23</a>&nbsp;&nbsp;&nbsp;<a href="page24.html">24</a>&nbsp;&nbsp;&nbsp;<a href="page25.html">25</a>&nbsp;&nbsp;&nbsp;<a href="page26.html">26</a>&nbsp;&nbsp;&nbsp;<a href="page27.html">27</a>&nbsp;&nbsp;&nbsp;<a href="page28.html">28</a>&nbsp;&nbsp;&nbsp;<a href="page29.html">29</a>
             </td>
             <td width="35%"><a href="page25.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page25.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
